Trial Profile
Clinical Trials Insight: 700056104
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 11 May 2010
Price :
$35
*
At a glance
- Drugs Bindarit (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- Sponsors Angelini Group
- 11 May 2010 New trial record